Merck shares plunge after Vioxx report

[camero]

http://www.stpetetimes.com/2004/11/01/Business/Merck_shares_plunged_.shtml

On Monday, Merck shares were down $2.22, or 7.1 percent, at $29.09 after The Wall Street Journal reported that internal e-mails and marketing materials show the company knew as far back as 2000 that Vioxx was linked to an increased risk of heart attack but tried to discredit such evidence.

Despite a March 9, 2000 e-mail from Merck research director Edward Scolnick to colleagues conceding an elevated risk of heart attack and stroke was "clearly there," according to the newspaper, Merck continued to try to discredit academic researchers critical of the drug.


The Journal reported that one training document from Merck listed potentially difficult questions about the drug and stated in capital letters, "DODGE!"

I'm glad I only took this drug for a week. Others were not so lucky. Not only are the drug companies gouging us, they're also lieing to us.

[camero]

1. kick

I guess I'm the only one that took this.

[silverpatronus]

2. i took it also...

for menstrual cramps. for a lot longer than a week. my doc took me off it a while ago though. put me on baralgin instead.

[camero]

3. I was on it 2 years after a car accident

When they finally did an MRI and found 3 nerves pinched. I'm glad the doc took you off.

This report speaks more to corporate corruption than anything and the lawsuits are just starting for Merck.